Back to search

Article

Genome-wide CRISPRa screens nominate modulators of CAR T cell survival within distinct tumor cytokine milieus

2024-03-17

Abstract excerpt

<h4>ABSTRACT</h4> Chimeric Antigen Receptor (CAR) T cell therapy has revolutionized the treatment of B cell malignancies and translating this success to other cancers remains an ongoing clinical objective. Next-generation T cell products in development aim to genetically modulate many facets of cell behavior, for which gene-nominating platforms provide a useful framework for prioritization. Among competing screen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
483953fd-eb05-5918-9c59-2c218ccf4f03
DOI
10.1101/2024.03.16.583115
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genome-wide CRISPRa screens nominate modulators of CAR T cell survival within distinct tumor cytokine milieusDOI 10.1101/2024.03.16.583115
Select a neighboring publication to make it the new centre.